aluates Reports

$ 0.0

Automative

Global Ischemia Reperfusion Injury Therapeutics Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-28M13666

Global Ischemia Reperfusion Injury Therapeutics Market Insights Forecast to 2029

BUY CHAPTERS

Global Ischemia Reperfusion Injury Therapeutics Market Research Report 2024

Code: QYRE-Auto-28M13666

Report

January 2024

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Ischemia Reperfusion Injury Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Ischemia Reperfusion Injury Therapeutics Market

The global Ischemia Reperfusion Injury Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Ischemia Reperfusion Injury Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ischemia Reperfusion Injury Therapeutics.

Report Scope

The Ischemia Reperfusion Injury Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ischemia Reperfusion Injury Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ischemia Reperfusion Injury Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ischemia Reperfusion Injury Therapeutics Market Report

Report Metric	Details
Report Name	Ischemia Reperfusion Injury Therapeutics Market
CAGR	5%
Segment by Type	ANV-6L15 APP-103 BAY-606583 EP-80317 GS-459679 KN-93 LH-021 Others
Segment by Application	Clinic Hospital Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nyken B.V., Omeros Corporation, Opsona Therapeutics Limited, Orexo AB, Pharming Group N.V., PledPharma AB, Prolong Pharmaceuticals, Proteo, Inc., Prothix BV, Stealth BioTherapeutics Inc., Zealand Pharma A/S, Amyndas Pharmaceuticals LLC, Angion Biomedica Corp., Antipodean Pharmaceuticals, Inc., Bayer AG, Biomedica Management Corporation, Bolder Biotechnology, Inc., Curatis Pharma GmbH, Ensemble Therapeutics Corporation, Erimos Pharmaceuticals, LLC, Gilead Sciences, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ischemia Reperfusion Injury Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ischemia Reperfusion Injury Therapeutics Market report?

Ans: The main players in the Ischemia Reperfusion Injury Therapeutics Market are Nyken B.V., Omeros Corporation, Opsona Therapeutics Limited, Orexo AB, Pharming Group N.V., PledPharma AB, Prolong Pharmaceuticals, Proteo, Inc., Prothix BV, Stealth BioTherapeutics Inc., Zealand Pharma A/S, Amyndas Pharmaceuticals LLC, Angion Biomedica Corp., Antipodean Pharmaceuticals, Inc., Bayer AG, Biomedica Management Corporation, Bolder Biotechnology, Inc., Curatis Pharma GmbH, Ensemble Therapeutics Corporation, Erimos Pharmaceuticals, LLC, Gilead Sciences, Inc.

What are the Application segmentation covered in the Ischemia Reperfusion Injury Therapeutics Market report?

Ans: The Applications covered in the Ischemia Reperfusion Injury Therapeutics Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Ischemia Reperfusion Injury Therapeutics Market report?

Ans: The Types covered in the Ischemia Reperfusion Injury Therapeutics Market report are ANV-6L15, APP-103, BAY-606583, EP-80317, GS-459679, KN-93, LH-021, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ischemia Reperfusion Injury Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 ANV-6L15

1.2.3 APP-103

1.2.4 BAY-606583

1.2.5 EP-80317

1.2.6 GS-459679

1.2.7 KN-93

1.2.8 LH-021

1.2.9 Others

1.3 Market by Application

1.3.1 Global Ischemia Reperfusion Injury Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ischemia Reperfusion Injury Therapeutics Market Perspective (2019-2030)

2.2 Ischemia Reperfusion Injury Therapeutics Growth Trends by Region

2.2.1 Global Ischemia Reperfusion Injury Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Ischemia Reperfusion Injury Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Ischemia Reperfusion Injury Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Ischemia Reperfusion Injury Therapeutics Market Dynamics

2.3.1 Ischemia Reperfusion Injury Therapeutics Industry Trends

2.3.2 Ischemia Reperfusion Injury Therapeutics Market Drivers

2.3.3 Ischemia Reperfusion Injury Therapeutics Market Challenges

2.3.4 Ischemia Reperfusion Injury Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ischemia Reperfusion Injury Therapeutics Players by Revenue

3.1.1 Global Top Ischemia Reperfusion Injury Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Ischemia Reperfusion Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Ischemia Reperfusion Injury Therapeutics Revenue

3.4 Global Ischemia Reperfusion Injury Therapeutics Market Concentration Ratio

3.4.1 Global Ischemia Reperfusion Injury Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ischemia Reperfusion Injury Therapeutics Revenue in 2023

3.5 Ischemia Reperfusion Injury Therapeutics Key Players Head office and Area Served

3.6 Key Players Ischemia Reperfusion Injury Therapeutics Product Solution and Service

3.7 Date of Enter into Ischemia Reperfusion Injury Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Ischemia Reperfusion Injury Therapeutics Breakdown Data by Type

4.1 Global Ischemia Reperfusion Injury Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Ischemia Reperfusion Injury Therapeutics Forecasted Market Size by Type (2025-2030)

5 Ischemia Reperfusion Injury Therapeutics Breakdown Data by Application

5.1 Global Ischemia Reperfusion Injury Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Ischemia Reperfusion Injury Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Ischemia Reperfusion Injury Therapeutics Market Size (2019-2030)

6.2 North America Ischemia Reperfusion Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2019-2024)

6.4 North America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ischemia Reperfusion Injury Therapeutics Market Size (2019-2030)

7.2 Europe Ischemia Reperfusion Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Ischemia Reperfusion Injury Therapeutics Market Size by Country (2019-2024)

7.4 Europe Ischemia Reperfusion Injury Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Ischemia Reperfusion Injury Therapeutics Market Size (2019-2030)

9.2 Latin America Ischemia Reperfusion Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Nyken B.V.

11.1.1 Nyken B.V. Company Detail

11.1.2 Nyken B.V. Business Overview

11.1.3 Nyken B.V. Ischemia Reperfusion Injury Therapeutics Introduction

11.1.4 Nyken B.V. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.1.5 Nyken B.V. Recent Development

11.2 Omeros Corporation

11.2.1 Omeros Corporation Company Detail

11.2.2 Omeros Corporation Business Overview

11.2.3 Omeros Corporation Ischemia Reperfusion Injury Therapeutics Introduction

11.2.4 Omeros Corporation Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.2.5 Omeros Corporation Recent Development

11.3 Opsona Therapeutics Limited

11.3.1 Opsona Therapeutics Limited Company Detail

11.3.2 Opsona Therapeutics Limited Business Overview

11.3.3 Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Introduction

11.3.4 Opsona Therapeutics Limited Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.3.5 Opsona Therapeutics Limited Recent Development

11.4 Orexo AB

11.4.1 Orexo AB Company Detail

11.4.2 Orexo AB Business Overview

11.4.3 Orexo AB Ischemia Reperfusion Injury Therapeutics Introduction

11.4.4 Orexo AB Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.4.5 Orexo AB Recent Development

11.5 Pharming Group N.V.

11.5.1 Pharming Group N.V. Company Detail

11.5.2 Pharming Group N.V. Business Overview

11.5.3 Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Introduction

11.5.4 Pharming Group N.V. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.5.5 Pharming Group N.V. Recent Development

11.6 PledPharma AB

11.6.1 PledPharma AB Company Detail

11.6.2 PledPharma AB Business Overview

11.6.3 PledPharma AB Ischemia Reperfusion Injury Therapeutics Introduction

11.6.4 PledPharma AB Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.6.5 PledPharma AB Recent Development

11.7 Prolong Pharmaceuticals

11.7.1 Prolong Pharmaceuticals Company Detail

11.7.2 Prolong Pharmaceuticals Business Overview

11.7.3 Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Introduction

11.7.4 Prolong Pharmaceuticals Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.7.5 Prolong Pharmaceuticals Recent Development

11.8 Proteo, Inc.

11.8.1 Proteo, Inc. Company Detail

11.8.2 Proteo, Inc. Business Overview

11.8.3 Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Introduction

11.8.4 Proteo, Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.8.5 Proteo, Inc. Recent Development

11.9 Prothix BV

11.9.1 Prothix BV Company Detail

11.9.2 Prothix BV Business Overview

11.9.3 Prothix BV Ischemia Reperfusion Injury Therapeutics Introduction

11.9.4 Prothix BV Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.9.5 Prothix BV Recent Development

11.10 Stealth BioTherapeutics Inc.

11.10.1 Stealth BioTherapeutics Inc. Company Detail

11.10.2 Stealth BioTherapeutics Inc. Business Overview

11.10.3 Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Introduction

11.10.4 Stealth BioTherapeutics Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.10.5 Stealth BioTherapeutics Inc. Recent Development

11.11 Zealand Pharma A/S

11.11.1 Zealand Pharma A/S Company Detail

11.11.2 Zealand Pharma A/S Business Overview

11.11.3 Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Introduction

11.11.4 Zealand Pharma A/S Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.11.5 Zealand Pharma A/S Recent Development

11.12 Amyndas Pharmaceuticals LLC

11.12.1 Amyndas Pharmaceuticals LLC Company Detail

11.12.2 Amyndas Pharmaceuticals LLC Business Overview

11.12.3 Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Introduction

11.12.4 Amyndas Pharmaceuticals LLC Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.12.5 Amyndas Pharmaceuticals LLC Recent Development

11.13 Angion Biomedica Corp.

11.13.1 Angion Biomedica Corp. Company Detail

11.13.2 Angion Biomedica Corp. Business Overview

11.13.3 Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Introduction

11.13.4 Angion Biomedica Corp. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.13.5 Angion Biomedica Corp. Recent Development

11.14 Antipodean Pharmaceuticals, Inc.

11.14.1 Antipodean Pharmaceuticals, Inc. Company Detail

11.14.2 Antipodean Pharmaceuticals, Inc. Business Overview

11.14.3 Antipodean Pharmaceuticals, Inc. Ischemia Reperfusion Injury Therapeutics Introduction

11.14.4 Antipodean Pharmaceuticals, Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.14.5 Antipodean Pharmaceuticals, Inc. Recent Development

11.15 Bayer AG

11.15.1 Bayer AG Company Detail

11.15.2 Bayer AG Business Overview

11.15.3 Bayer AG Ischemia Reperfusion Injury Therapeutics Introduction

11.15.4 Bayer AG Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.15.5 Bayer AG Recent Development

11.16 Biomedica Management Corporation

11.16.1 Biomedica Management Corporation Company Detail

11.16.2 Biomedica Management Corporation Business Overview

11.16.3 Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Introduction

11.16.4 Biomedica Management Corporation Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.16.5 Biomedica Management Corporation Recent Development

11.17 Bolder Biotechnology, Inc.

11.17.1 Bolder Biotechnology, Inc. Company Detail

11.17.2 Bolder Biotechnology, Inc. Business Overview

11.17.3 Bolder Biotechnology, Inc. Ischemia Reperfusion Injury Therapeutics Introduction

11.17.4 Bolder Biotechnology, Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.17.5 Bolder Biotechnology, Inc. Recent Development

11.18 Curatis Pharma GmbH

11.18.1 Curatis Pharma GmbH Company Detail

11.18.2 Curatis Pharma GmbH Business Overview

11.18.3 Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Introduction

11.18.4 Curatis Pharma GmbH Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.18.5 Curatis Pharma GmbH Recent Development

11.19 Ensemble Therapeutics Corporation

11.19.1 Ensemble Therapeutics Corporation Company Detail

11.19.2 Ensemble Therapeutics Corporation Business Overview

11.19.3 Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Introduction

11.19.4 Ensemble Therapeutics Corporation Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.19.5 Ensemble Therapeutics Corporation Recent Development

11.20 Erimos Pharmaceuticals, LLC

11.20.1 Erimos Pharmaceuticals, LLC Company Detail

11.20.2 Erimos Pharmaceuticals, LLC Business Overview

11.20.3 Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Introduction

11.20.4 Erimos Pharmaceuticals, LLC Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.20.5 Erimos Pharmaceuticals, LLC Recent Development

11.21 Gilead Sciences, Inc.

11.21.1 Gilead Sciences, Inc. Company Detail

11.21.2 Gilead Sciences, Inc. Business Overview

11.21.3 Gilead Sciences, Inc. Ischemia Reperfusion Injury Therapeutics Introduction

11.21.4 Gilead Sciences, Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

11.21.5 Gilead Sciences, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Ischemia Reperfusion Injury Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of ANV-6L15

Table 3. Key Players of APP-103

Table 4. Key Players of BAY-606583

Table 5. Key Players of EP-80317

Table 6. Key Players of GS-459679

Table 7. Key Players of KN-93

Table 8. Key Players of LH-021

Table 9. Key Players of Others

Table 10. Global Ischemia Reperfusion Injury Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 11. Global Ischemia Reperfusion Injury Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Ischemia Reperfusion Injury Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 13. Global Ischemia Reperfusion Injury Therapeutics Market Share by Region (2019-2024)

Table 14. Global Ischemia Reperfusion Injury Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 15. Global Ischemia Reperfusion Injury Therapeutics Market Share by Region (2025-2030)

Table 16. Ischemia Reperfusion Injury Therapeutics Market Trends

Table 17. Ischemia Reperfusion Injury Therapeutics Market Drivers

Table 18. Ischemia Reperfusion Injury Therapeutics Market Challenges

Table 19. Ischemia Reperfusion Injury Therapeutics Market Restraints

Table 20. Global Ischemia Reperfusion Injury Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 21. Global Ischemia Reperfusion Injury Therapeutics Market Share by Players (2019-2024)

Table 22. Global Top Ischemia Reperfusion Injury Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemia Reperfusion Injury Therapeutics as of 2023)

Table 23. Ranking of Global Top Ischemia Reperfusion Injury Therapeutics Companies by Revenue (US$ Million) in 2023

Table 24. Global 5 Largest Players Market Share by Ischemia Reperfusion Injury Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Ischemia Reperfusion Injury Therapeutics Product Solution and Service

Table 27. Date of Enter into Ischemia Reperfusion Injury Therapeutics Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Ischemia Reperfusion Injury Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 30. Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Type (2019-2024)

Table 31. Global Ischemia Reperfusion Injury Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 32. Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Type (2025-2030)

Table 33. Global Ischemia Reperfusion Injury Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 34. Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Application (2019-2024)

Table 35. Global Ischemia Reperfusion Injury Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 36. Global Ischemia Reperfusion Injury Therapeutics Revenue Market Share by Application (2025-2030)

Table 37. North America Ischemia Reperfusion Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Ischemia Reperfusion Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Europe Ischemia Reperfusion Injury Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Europe Ischemia Reperfusion Injury Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 44. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 45. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 46. Latin America Ischemia Reperfusion Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Latin America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 48. Latin America Ischemia Reperfusion Injury Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 49. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 50. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 51. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 52. Nyken B.V. Company Detail

Table 53. Nyken B.V. Business Overview

Table 54. Nyken B.V. Ischemia Reperfusion Injury Therapeutics Product

Table 55. Nyken B.V. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 56. Nyken B.V. Recent Development

Table 57. Omeros Corporation Company Detail

Table 58. Omeros Corporation Business Overview

Table 59. Omeros Corporation Ischemia Reperfusion Injury Therapeutics Product

Table 60. Omeros Corporation Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 61. Omeros Corporation Recent Development

Table 62. Opsona Therapeutics Limited Company Detail

Table 63. Opsona Therapeutics Limited Business Overview

Table 64. Opsona Therapeutics Limited Ischemia Reperfusion Injury Therapeutics Product

Table 65. Opsona Therapeutics Limited Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 66. Opsona Therapeutics Limited Recent Development

Table 67. Orexo AB Company Detail

Table 68. Orexo AB Business Overview

Table 69. Orexo AB Ischemia Reperfusion Injury Therapeutics Product

Table 70. Orexo AB Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 71. Orexo AB Recent Development

Table 72. Pharming Group N.V. Company Detail

Table 73. Pharming Group N.V. Business Overview

Table 74. Pharming Group N.V. Ischemia Reperfusion Injury Therapeutics Product

Table 75. Pharming Group N.V. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 76. Pharming Group N.V. Recent Development

Table 77. PledPharma AB Company Detail

Table 78. PledPharma AB Business Overview

Table 79. PledPharma AB Ischemia Reperfusion Injury Therapeutics Product

Table 80. PledPharma AB Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 81. PledPharma AB Recent Development

Table 82. Prolong Pharmaceuticals Company Detail

Table 83. Prolong Pharmaceuticals Business Overview

Table 84. Prolong Pharmaceuticals Ischemia Reperfusion Injury Therapeutics Product

Table 85. Prolong Pharmaceuticals Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 86. Prolong Pharmaceuticals Recent Development

Table 87. Proteo, Inc. Company Detail

Table 88. Proteo, Inc. Business Overview

Table 89. Proteo, Inc. Ischemia Reperfusion Injury Therapeutics Product

Table 90. Proteo, Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 91. Proteo, Inc. Recent Development

Table 92. Prothix BV Company Detail

Table 93. Prothix BV Business Overview

Table 94. Prothix BV Ischemia Reperfusion Injury Therapeutics Product

Table 95. Prothix BV Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 96. Prothix BV Recent Development

Table 97. Stealth BioTherapeutics Inc. Company Detail

Table 98. Stealth BioTherapeutics Inc. Business Overview

Table 99. Stealth BioTherapeutics Inc. Ischemia Reperfusion Injury Therapeutics Product

Table 100. Stealth BioTherapeutics Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 101. Stealth BioTherapeutics Inc. Recent Development

Table 102. Zealand Pharma A/S Company Detail

Table 103. Zealand Pharma A/S Business Overview

Table 104. Zealand Pharma A/S Ischemia Reperfusion Injury Therapeutics Product

Table 105. Zealand Pharma A/S Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 106. Zealand Pharma A/S Recent Development

Table 107. Amyndas Pharmaceuticals LLC Company Detail

Table 108. Amyndas Pharmaceuticals LLC Business Overview

Table 109. Amyndas Pharmaceuticals LLC Ischemia Reperfusion Injury Therapeutics Product

Table 110. Amyndas Pharmaceuticals LLC Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 111. Amyndas Pharmaceuticals LLC Recent Development

Table 112. Angion Biomedica Corp. Company Detail

Table 113. Angion Biomedica Corp. Business Overview

Table 114. Angion Biomedica Corp. Ischemia Reperfusion Injury Therapeutics Product

Table 115. Angion Biomedica Corp. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 116. Angion Biomedica Corp. Recent Development

Table 117. Antipodean Pharmaceuticals, Inc. Company Detail

Table 118. Antipodean Pharmaceuticals, Inc. Business Overview

Table 119. Antipodean Pharmaceuticals, Inc. Ischemia Reperfusion Injury Therapeutics Product

Table 120. Antipodean Pharmaceuticals, Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 121. Antipodean Pharmaceuticals, Inc. Recent Development

Table 122. Bayer AG Company Detail

Table 123. Bayer AG Business Overview

Table 124. Bayer AG Ischemia Reperfusion Injury Therapeutics Product

Table 125. Bayer AG Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 126. Bayer AG Recent Development

Table 127. Biomedica Management Corporation Company Detail

Table 128. Biomedica Management Corporation Business Overview

Table 129. Biomedica Management Corporation Ischemia Reperfusion Injury Therapeutics Product

Table 130. Biomedica Management Corporation Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 131. Biomedica Management Corporation Recent Development

Table 132. Bolder Biotechnology, Inc. Company Detail

Table 133. Bolder Biotechnology, Inc. Business Overview

Table 134. Bolder Biotechnology, Inc. Ischemia Reperfusion Injury Therapeutics Product

Table 135. Bolder Biotechnology, Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 136. Bolder Biotechnology, Inc. Recent Development

Table 137. Curatis Pharma GmbH Company Detail

Table 138. Curatis Pharma GmbH Business Overview

Table 139. Curatis Pharma GmbH Ischemia Reperfusion Injury Therapeutics Product

Table 140. Curatis Pharma GmbH Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 141. Curatis Pharma GmbH Recent Development

Table 142. Ensemble Therapeutics Corporation Company Detail

Table 143. Ensemble Therapeutics Corporation Business Overview

Table 144. Ensemble Therapeutics Corporation Ischemia Reperfusion Injury Therapeutics Product

Table 145. Ensemble Therapeutics Corporation Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 146. Ensemble Therapeutics Corporation Recent Development

Table 147. Erimos Pharmaceuticals, LLC Company Detail

Table 148. Erimos Pharmaceuticals, LLC Business Overview

Table 149. Erimos Pharmaceuticals, LLC Ischemia Reperfusion Injury Therapeutics Product

Table 150. Erimos Pharmaceuticals, LLC Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 151. Erimos Pharmaceuticals, LLC Recent Development

Table 152. Gilead Sciences, Inc. Company Detail

Table 153. Gilead Sciences, Inc. Business Overview

Table 154. Gilead Sciences, Inc. Ischemia Reperfusion Injury Therapeutics Product

Table 155. Gilead Sciences, Inc. Revenue in Ischemia Reperfusion Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 156. Gilead Sciences, Inc. Recent Development

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Ischemia Reperfusion Injury Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Ischemia Reperfusion Injury Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. ANV-6L15 Features

Figure 4. APP-103 Features

Figure 5. BAY-606583 Features

Figure 6. EP-80317 Features

Figure 7. GS-459679 Features

Figure 8. KN-93 Features

Figure 9. LH-021 Features

Figure 10. Others Features

Figure 11. Global Ischemia Reperfusion Injury Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 12. Global Ischemia Reperfusion Injury Therapeutics Market Share by Application: 2023 VS 2030

Figure 13. Clinic Case Studies

Figure 14. Hospital Case Studies

Figure 15. Others Case Studies

Figure 16. Ischemia Reperfusion Injury Therapeutics Report Years Considered

Figure 17. Global Ischemia Reperfusion Injury Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Ischemia Reperfusion Injury Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Ischemia Reperfusion Injury Therapeutics Market Share by Region: 2023 VS 2030

Figure 20. Global Ischemia Reperfusion Injury Therapeutics Market Share by Players in 2023

Figure 21. Global Top Ischemia Reperfusion Injury Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ischemia Reperfusion Injury Therapeutics as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Ischemia Reperfusion Injury Therapeutics Revenue in 2023

Figure 23. North America Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Ischemia Reperfusion Injury Therapeutics Market Share by Country (2019-2030)

Figure 25. United States Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Ischemia Reperfusion Injury Therapeutics Market Share by Country (2019-2030)

Figure 29. Germany Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Ischemia Reperfusion Injury Therapeutics Market Share by Region (2019-2030)

Figure 37. China Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Ischemia Reperfusion Injury Therapeutics Market Share by Country (2019-2030)

Figure 45. Mexico Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Ischemia Reperfusion Injury Therapeutics Market Share by Country (2019-2030)

Figure 49. Turkey Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Ischemia Reperfusion Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Nyken B.V. Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 52. Omeros Corporation Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 53. Opsona Therapeutics Limited Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 54. Orexo AB Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 55. Pharming Group N.V. Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 56. PledPharma AB Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 57. Prolong Pharmaceuticals Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 58. Proteo, Inc. Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 59. Prothix BV Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 60. Stealth BioTherapeutics Inc. Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 61. Zealand Pharma A/S Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 62. Amyndas Pharmaceuticals LLC Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 63. Angion Biomedica Corp. Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 64. Antipodean Pharmaceuticals, Inc. Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 65. Bayer AG Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 66. Biomedica Management Corporation Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 67. Bolder Biotechnology, Inc. Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 68. Curatis Pharma GmbH Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 69. Ensemble Therapeutics Corporation Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 70. Erimos Pharmaceuticals, LLC Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 71. Gilead Sciences, Inc. Revenue Growth Rate in Ischemia Reperfusion Injury Therapeutics Business (2019-2024)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Ischemia Reperfusion Injury Therapeutics Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-28M13666

Global Ischemia Reperfusion Injury Therapeutics Market Research Report 2024

FEATURED COMPANIES

Ischemia Reperfusion Injury Therapeutics Market Size

Ischemia Reperfusion Injury Therapeutics Market

Report Scope

Scope of Ischemia Reperfusion Injury Therapeutics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Ischemia Reperfusion Injury Therapeutics Market report?

What are the Application segmentation covered in the Ischemia Reperfusion Injury Therapeutics Market report?

What are the Type segmentation covered in the Ischemia Reperfusion Injury Therapeutics Market report?

FEATURED COMPANIES